PT  - JOURNAL ARTICLE
AU  - Ayele, Biniyam A.
AU  - Whitehead, Patrice L.
AU  - Pascual, Julianna
AU  - Gu, Tianjie
AU  - Arvizu, Jamie
AU  - Golightly, Charles G.
AU  - Adams, Larry D.
AU  - Pericak-Vance, Margaret A.
AU  - Vance, Jeffery M.
AU  - Griswold, Anthony J.
TI  - AD plasma biomarkers are stable for an extended period at –20°C: implications for resource-constrained environments
AID  - 10.1101/2024.07.17.24310504
DP  - 2024 Jan 01
TA  - medRxiv
PG  - 2024.07.17.24310504
4099  - http://medrxiv.org/content/early/2024/07/17/2024.07.17.24310504.short
4100  - http://medrxiv.org/content/early/2024/07/17/2024.07.17.24310504.full
AB  - Standard procedures for measuring Alzheimer’s disease (AD) plasma biomarkers include storage at -80°C. This is challenging in countries lacking research infrastructure, such -80°C freezer. To investigate stability of AD biomarkers from plasma stored at -20°C, we compared aliquots stored at -80°C and others at -20°C for two, four, six, fifteen, and thirty-five weeks. pTau181, Aβ42, Aβ40, NfL, and GFAP were measured for each timepoint. pTau181 and Aβ42/Aβ40 ratios showed minimal variation for up to 15 weeks. NfL and GFAP had higher variability. This finding of 15-week stability at -20°C enables greater participation in AD biomarker studies in resource constrained environments.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe study was funded by National Insisitute of Aging through the following AG074865, AG072547, AG076482, AG062943, AG057659, AG066767 grants.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethics committee/IRB of University of Miami gave ethical approval for this work.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors.